Headlines

Go To Pro Hockey Rumors
Go To Hoops Rumors

Newsstand

Christian Encarnacion-Strand To Undergo Wrist Surgery

By | at

Reds infielder Christian Encarnacion-Strand will have wrist surgery on July 11 and there’s a three-month recovery timeline. If that timeline holds, that means he won’t be able to return during the regular season. Manager David Bell relayed the information to reporters today, with Charlie Goldsmith of the Cincinnati Enquirer among those to pass it along. X link one and two.

It’s been a frustrating and unusual saga for Encarnacion-Strand. Back at the end of April, he was hit on the hand by a pitch and X-rays were negative but revealed a small pre-existing fracture. The infielder said he didn’t know how that came about and that he wasn’t in any discomfort prior to being hit by that pitch.

He was placed on the injured list about a week later, with the club describing his ailment as a right ulnar styloid fracture. Just over a week ago, Bell revealed that surgery was being considered and it now seems that it has been deemed necessary. Given the three-month recovery timeline, Encarnacion-Strand won’t be able to return this year unless the club makes the playoffs and survives through the middle of October. Even if that does come to pass, it will be a challenge for him to get back into game shape and earn his way onto the roster, so it seems there’s a decent chance his 2024 is effectively done.

That’s a very frustrating blow for Encarnacion-Strand and the club. A highly-touted prospect, he debuted with a splash last year by hitting 13 home runs in his first 63 major league games. He slashed .270/.328/.477 overall for a wRC+ of 112.

He was undoubtedly hoping to build off that with a healthy and productive showing in his first full season, but it hasn’t come to pass. He hit just .190/.220/.293 in his 29 games this year and that will almost certainly be his final line when the year is over. He’s already on the 60-day injured list and is now slated to stay there for the rest of the campaign.

For the team, this just adds to the number of missed opportunities by their players this year. Noelvi Marté was hit with an 80-game PED suspension and has missed the entire season thus far. Injuries have plagued Matt McLain, TJ Friedl and various pitchers on their staff, leaving the club fairly hampered all year long.

Their season is still alive thanks to the weak National League Wild Card race. The Reds are just 37-41 but that is only 2.5 games out of a playoff spot at the moment. That’s somewhat encouraging but it also leads to plenty of “what if” questions amid all the various issues the club has dealt with.

Encarnacion-Strand was the everyday first baseman prior to the landing on the injured list but that job has primarily fallen to Spencer Steer in recent months. Marté could return soon to possibly factor into the third base mix and perhaps that will lead to Jeimer Candelario moving over to first base at times. That could push Steer into a corner outfield role, where Will Benson and Jake Fraley are having underwhelming seasons.

Edwin Diaz Given 10-Game Suspension For Foreign Substance Check

By | at

June 25: Diaz will not appeal and will start serving his suspension tonight. Joel Sherman of The New York Post was among those to relay the news on X.

June 24: As expected, Diaz has received a 10-game suspension. Jon Heyman of The New York Post was among those to relay the news on X. The righty can appeal the decision but it’s not yet clear if he will.

June 23: Mets closer Edwin Diaz was ejected from tonight’s game due to an apparent use of an illegal substance on his hands.  Diaz was taking the field in the bottom of the ninth to try and preserve a 5-2 New York lead, but after the standard check every pitcher receives before entering and exiting games, crew chief Vic Carapazza tossed Diaz from the game.  Drew Smith and Jake Diekman combined for a scoreless inning to preserve the Mets’ victory over the Cubs.

As per league rules, Diaz now faces a mandatory 10-game suspension for use of foreign substances.  He won’t be paid for those 10 games, and the Mets aren’t allowed to replace him on the roster, so the club will have to field a 25-man roster over the course of Diaz’s suspension.  Diaz has the right to an appeal, so it is possible he might receive fewer than a 10-game ban, even if that scenario is rather unlikely given the seemingly apparent evidence.

Diaz is the third Mets pitcher in the last two seasons to be tossed for a game for use of an illegal substance, as both Smith and Max Scherzer received 10-game suspensions during the 2023 campaign.  Similar suspensions were issued to the Astros’ Ronel Blanco earlier this season, and to Robert Suarez and Domingo German last year.

Tonight’s incident is the latest turn in an up-and-down comeback season for Diaz, who missed all of the 2023 season due to a torn patellar tendon.  Diaz has a 4.70 ERA over 23 innings and 23 appearances this season, recording seven saves in 11 chances.  While he looked pretty close to his past All-Star form early in the year, a few shaky outings led the Mets to move Diaz into lower-leverage situations, and he was then sidelined entirely due to a shoulder impingement.

The right-hander missed a little over three weeks due to the injury, and has looked sharp in his three outings since being activated off the 15-day IL.  Diaz has tossed three scoreless innings and earned two saves and a win in those three games, while allowing two hits and no walks, and striking out three batters.

He’ll now get another unwelcome break from action while serving his suspension, leaving the Mets likely to return to the closer committee approach they used earlier this season when Diaz was both injured and out of the closer’s role.  Diaz’s absence throws a wrench into the momentum of a New York that has won 13 of its last 17 teams, and gotten back into the hunt for a wild card berth.

Yankees Acquire J.D. Davis

By | at

The Yankees announced this afternoon that they’ve acquired infielder J.D. Davis and cash considerations from the A’s in exchange infielder Jordan Groshans. Davis had been designated for assignment by the A’s earlier this week. The Yankees transferred right-hander Nick Burdi to the 60-day injured list in order to make room for Davis on the 40-man roster.

Davis, 31, signed with the A’s in late spring after the Giants released Davis during Spring Training in order to get out from under most of the $6.9MM salary he had been awarded in arbitration over the winter. He managed to secure a guarantee of just $2.5MM from Oakland, a far cry from his previously-awarded arbitration salary even after factoring in the roughly $1.1MM in termination pay he received from San Francisco.

After that late spring controversy, Davis went on to appear in 39 games with the A’s where he slashed a roughly league-average .236/.304/.366 in 135 trips to the plate while splitting time between first base, third base, and DH. While his offensive numbers this year leave something to be desired, Davis’s positional versatility and track record as an above-average hitter make him a perfect fit for the Yankees’ current needs.

The club lost starting DH Giancarlo Stanton to the injured list earlier today, and first baseman Anthony Rizzo was also placed on the shelf not long ago due to a fractured forearm. Rookie Ben Rice has scuffled a bit in his first few games replacing Rizzo at first base, while the club has no obvious alternative to Stanton as an everyday DH in-house. Even at third base, where the club is currently relying on the combination of Oswaldo Cabrera and DJ LeMahieu, New York has gotten a wRC+ of just 78 — this ranks second-worst of all AL third-base units, ahead of only the White Sox.

Enter Davis, who entered the 2024 season with five consecutive seasons of solid production with the Mets and Giants. Since the start of the 2019 season, Davis has slashed a solid .265/.349/.438 with a wRC+ of 118. While he’s struck out a 27.1% clip during that time, he’s walked at a healthy 10% rate while flashing 20-homer power. That sort of production would be a major upgrade for a Yankees club that has generally struggled to produce offense outside of the outfield this year even before losing Stanton for at least the short-term. Davis seems likely to slide into the everyday DH role for the Yankees while Stanton is unavailable, but could also spell Rice at first base against left-handed pitching and even contribute at third alongside LeMahieu and Cabrera.

On days where Davis is playing the infield, the Yankees could offer Aaron Judge or Juan Soto the opportunity to get a half-day of rest as a DH and improve the club’s outfield defense by inserting glove-first center fielder Trent Grisham into the mix. When Stanton eventually returns to reclaim regular DH, the Yankees could pick and choose from Davis, Rice, Cabrera, and LeMahieu based on how everyone is performingt. That being said, if Davis can even maintain his production as an Athletic in the Bronx he should be a shoe-in for at least semi-regular playing time around the Yankees infield even after Stanton’s eventual return.

In exchange for Davis’ services, the Yankees are sending Groshans to Oakland. The 24-year-old’s stint in the Yankees organization was a relatively brief one, as the club claimed him off waivers from the Marlins back in February. He was outrighted off their 40-man roster in early March and has struggled to this point in the 2024 season with a .232/.310/.281 slash line while playing all four infield spots in 50 games split between the Double- and Triple-A levels. That follows a similarly rough performance at Triple-A with Miami last year; in 528 plate appearances across 125 games in 2023, Groshans slashed a paltry .244/.339/.330 with just six home runs.

Despite Groshans’ struggles over the past two seasons, it’s not hard to see why the A’s would be willing to give the youngster a shot. After all, the infielder was the 12th overall pick in the 2018 draft by the Blue Jays and received plenty of top prospect buzz earlier in his career, including a stint as a consensus top-50 prospect in the sport back in 2021. That pedigree combined with Groshans’ stronger numbers at the Double-A level earlier in his career provide some reason for optimism that he could contribute at the big league level at some point.

That possibility is surely an attractive one for an Oakland club that has struggled to find a consistent option at third base this year while cycling between Davis, Abraham Toro, and Tyler Nevin at the position. Toro will be out until at least the All-Star break recovering from a hamstring strain, leaving even more opportunity for Groshans to win some playing time at the hot corner.

Marlins Place Braxton Garrett On 15-Day Injured List With Forearm Flexor Strain

By | at

The Marlins announced several roster moves this morning, headlined by the club placing left-hander Braxton Garrett on the 15-Day injured list with a left forearm flexor strain. The club also optioned right-hander Shaun Anderson to Triple-A. Taking Garrett and Anderson’s spots on the club’s active roster will be right-hander Kyle Tyler and left-hander Kent Emanuel, both of whom had their contracts selected. Left-hander Jesus Luzardo and right-hander Edward Cabrera were both transferred to the 60-day injured list to clear space for the duo on the 40-man roster.

Garrett’s placement on the injured list isn’t necessarily a surprise, as the club had already scratched him from today’s start due to elbow soreness yesterday. With that being said, the diagnosis of a forearm flexor strain is a concerning one that suggests Garrett could be in for a lengthy absence, though details about his exact timeline are not yet available. For Marlins fans, it surely brings to mind September of last year, when the Marlins provided the same diagnosis for right-hander Sandy Alcantara before the ace ultimately required Tommy John surgery.

Fortunately, not all forearm strains require such drastic treatment. Nationals right-hander Josiah Gray suffered a similarly-termed strain back in April that ultimately proved to be purely muscular without damage to the UCL. Gray is currently on a rehab assignment and could factor into the Nationals’ pitching plans prior to the All Star break, roughly three months after the initial injury. A similar timeline could see Cabrera return sometime in September, prior to the end of the 2024 campaign.

Regardless of when Cabrera winds up being able to return to the club, however, the Marlins figure to be in a bit of a pickle as they look to piece together their rotation mix. Miami currently has seven starters on the injured list, leaving them with lefty Trevor Rogers, righty Roddery Munoz, and righty Yonny Chirinos as their only three established starting pitchers. That trio will be joined by Tyler, who is slated to start today’s game against the Mariners. A 20th-round pick by the Angels in the 2018 draft, the righty has made eight multi-inning relief appearances in the big leagues since he first made his MLB debut back in 2021, though he’s never started a game at the big league level.

He’s pitched fairly well in his limited opportunities in the majors with a 2.45 ERA and 4.36 FIP in 18 1/3 innings of work. That includes a single appearance with the Marlins earlier this year where he allowed one run in two frames where he allowed one hit and no walks with one strikeout. It’s unclear if Tyler will continue to pitch as part of the club’s rotation after today or if this is a spot start for the 27-year-old. Also joining Tyler on the active roster is the lefty Emanuel, who has been shuttling between the 40-man roster and the minor leagues all throughout the 2024 campaign for the Marlins. In 8 1/3 innings of work for the club this year across four appearances, Emanuel has struggled to a 7.56 ERA with an 8.19 FIP. Nonetheless, the southpaw will provide the club with a multi-inning option out of the bullpen who could piggyback with the right-handed Tyler if necessary this afternoon.

As for Luzardo and Cabrerea, the 60-day IL placements come as a mild surprise for both players. In Luzardo’s case, the lefty was placed on the IL just yesterday with a lumbar stress reaction, and manager Skip Schumaker suggested that injury typically has a 4-6 week timeline. Now that Luzardo is out for at least the next two months, it’s safe to say the Marlins believe he’ll be out for longer than that general timeline. He’ll first be eligible to return from the shelf in late August. Cabrera’s placement also somewhat surprising given the fact that he’s already built up to the 50-pitch range on a rehab assignment, though given the fact that the righty would be eligible to be activated from the shelf in just two weeks it could be a purely procedural transaction.

Orelvis Martinez Receives 80-Game Suspension Following Positive PED Test

By | at

The MLB commissioner’s office announced this morning that Blue Jays infielder Orelvis Martinez has received an 80-game suspension without pay after testing positive for Clomiphene, a banned performance enhancing substance. The suspension is effective immediately. Martinez has since been placed on the restricted list, and the Blue Jays have selected the contract of outfielder Steward Berroa to replace the infielder on the active and 40-man rosters.

“The Blue Jays fully support Major League Baseball’s Joint Drug Prevention and Treatment Program, and strongly believe in keeping the game on a level playing field,” Blue Jays GM Ross Atkins said in a statement this morning. “We were both surprised and disappointed to hear of Orelvis Martinez’s suspension. We will do everything in our power to ensure Orelvis has learned from this mistake. Orelvis has our support, and we know he will get through this.”

Martinez released a statement of his own via the MLB Players Association:

“For the past two years, I have been trying to start a family with my girlfriend. During the offseason, we visited a fertility clinic in the Dominican Republic and after getting lab work done, we were prescribed a treatment, which included a medication called Rejun 50. Unfortunately, Rejun 50 contains a banned substance called Clomiphene.

We wanted to keep this matter private, even within our family, and trusted the doctor who assured us this treatment did not include performance enhancing drugs. Therefore, I made the mistake of not disclosing this to my team or the MLBPA. With that said, I took full responsibility for my actions and accepted my suspension.

I want to apologize to my teammates in both Buffalo and Toronto, the Blue Jays organization, and most importantly, the fans who have supported me during my career. I will learn from this experience and come back to the field in September.”

The news is a major blow to the Blue Jays, who recalled Martinez for his big league debut just this past week to join the club’s infield mix after shortstop Bo Bichette hit the injured list with a calf strain. Martinez has just one game under his belt in the majors so far, having gone 1-for-3 with a strikeout while playing second base in his big league debut on Friday. While Martinez’s big league career had only just begun, he’s long been considered a consensus top-100 prospect in the sport and was in the midst of an excellent showing at Triple-A this year when he received the call to the majors. In 63 games for the club’s Buffalo affiliate this year, Martinez slashed .260/.343/.523 while playing both second and third base.

Now, Martinez’s big league career is on hold just days after it first began. The earliest he’ll be able to return to play in the big leagues is September 23 against the Red Sox, although given the fact that Martinez would be ineligible to participate in the postseason due to his suspension and that date landing just six games before the end of the regular season, it wouldn’t be a surprise if Martinez did not end up returning to the majors until the 2025 campaign.

Fortunately for the Blue Jays, the club has plenty of options at its disposal to fill out the club’s infield mix while Bichette is injured, even without Martinez. Isiah Kiner-Falefa has stepped into the everyday role at shortstop since Bichette hit the shelf last week, and the club figures to mix and match between Davis Schneider, Ernie Clement, Addison Barger, and Spencer Horwitz at second and third base while Bichette is away. The addition of Berroa to the roster mix should allow Schneider to mix into the infield more frequently than he has in recent weeks, as he’s split time between the keystone and left field to this point in the season.

As for Berroa, the 25-year-old made his pro debut with the Jays back in 2017 and has worked his way through the club’s minor league system since then, ultimately reaching Triple-A late last year. He struggled in that initial cup of coffee but has hit fairly well in 62 games at the highest level of the minors this season with a .295/.380/.451 slash line across 222 trips to the plate. Berroa figures to factor into the club’s outfield mix behind regulars Daulton Varsho, Kevin Kiermaier, and George Springer alongside Schneider.

Phillies Extend Cristopher Sanchez

By | at

3:25PM: According to The Athletic’s Matt Gelb, the extension will guarantee Sanchez $22.5MM in total. The club option year for 2029 is valued at $14MM, while the 2030 club option is worth $15MM. Gelb adds that the price of both options will rise if Sanchez manages to finish in the top 10 of NL Cy Young award voting.

10:33AM: The Phillies have officially announced the extension, with no financial terms released.  Sanchez’s deal covers the 2025-28 seasons, and Philadelphia has club options on his services for both 2029 and 2030.

9:10AM: The Phillies and left-hander Cristopher Sanchez are in the final stages of completing a four-year contract extension, the New York Post’s Jon Heyman reports (X link).  Sanchez is already under team control through the 2028 season, so the deal will give the Phils some cost certainty over those upcoming four years and beyond.  Heyman indicates there are multiple club option years, so the Phillies can now control at least two of Sanchez’s free agent seasons.  The 27-year-old Sanchez is represented by agent Gene Mato.

The signing continues Philadelphia’s penchant for locking up arms, as all of the extensions signed during Dave Dombrowski’s tenure as president of baseball operations have come on the pitching end.  These deals range from shorter-term deals to avoid arbitration to the much pricier three-year, $126MM extension Zack Wheeler signed last March, and Sanchez’s deal should fall somewhere in between.

Considering Sanchez’s relatively advanced age (he turns 28 in December) and the fact that he isn’t even eligible for arbitration until the 2025-26 offseason, an extension is an aggressive move on the part of Dombrowski’s front office.  While the southpaw was lining himself up well for some nice salaries in his arb years, having a relatively inexpensive arm in the rotation could have helped balance out the much larger luxury tax hits of pricier players like Wheeler, Bryce Harper, Trea Turner, and Aaron Nola, all of whom are signed through at least the 2027 season.  Nick Castellanos and Taijuan Walker also on the books through 2026, J.T. Realmuto and Kyle Schwarber through 2025, and the likes of Ranger Suarez, Alec Bohm, and Bryson Stott have also played well enough to merit consideration for long-term commitments.

The Phillies surpassed the luxury tax threshold in each of the last two seasons and are set to do again in 2024, as the team has shown it is more than willing to spend big in pursuit of a championship.  Against this backdrop, it isn’t surprising that the Phils are again opening the checkbook to retain a player they like, and who they feel might end up being something of a bargain over the course of the extension, considering how Sanchez has emerged as a starter in 2023-24.

An international signing for the Rays out of the Dominican Republic in 2013, Sanchez was dealt to Philadelphia in November 2019 in a one-for-one trade for Curtis Mead.  An under-the-radar move at the time, it has become a pretty intriguing deal in hindsight given how Sanchez has developed as a capable MLB starter, and how Mead went on to become a top-100 prospect in Tampa’s farm system (and a big leaguer himself, albeit in only 50 games to date).

Sanchez showed some flashes of his future ability as a starter and a reliever during his time in the Rays’ farm system, and the Phillies used him mostly as a starter during his time in the minors.  He made his MLB debut in 2021 and still worked as a reliever in all but four of his big league outings (52 2/3 innings over 23 appearances) in 2021-22, but some injuries opened the door for Sanchez to eventually step into the Philadelphia rotation himself last season.  The result was a 3.44 ERA over 99 1/3 innings, supported by a 24.2% strikeout rate, a four percent walk rate, and a 57% grounder rate.

That success has largely carried over to this season, as Sanchez has a 2.91 ERA, 20.3% strikeout rate, 7.4% walk rate, and a 59.4% grounder rate.  While the walk rate is no longer elite and Sanchez’s K% is now below average, he is still generating tons of grounders, and could even be considered somewhat unlucky since he has a .342 BABIP.  Sanchez is doing a solid job of limiting hard contract and in particular of keeping the ball in the park — after allowing 16 homers in his 99 1/3 innings in 2023, Sanchez has given up just one home run in 77 1/3 frames this year.  While not a particularly hard thrower in relation to the rest of the league, Sanchez has added quite a bit of velocity, now averaging 94.3mph on his fastball after averaging 92.1mph last year.

This grounder-heavy and relatively low-strikeout skillset could lend itself to some variance if the ground balls start finding holes in the infield, or if Sanchez’s newfound success at limiting homers doesn’t continue.  That said, the Phillies are obviously confident enough in Sanchez as a viable rotation member that they have now firmed up their commitment to him for much of the decade.

From Sanchez’s perspective, he’ll now land the first big payday of his professional career.  Since he wouldn’t have entered free agency until after his age-31 season, Sanchez will gain some life-changing financial ability now, rather than run the risk that an injury or a dip in form might’ve scuttled his future chances at a big multi-year contract.

Looking at the bigger picture of the Phillies’ pitching situation, extending Sanchez creates some new questions about whether or not retaining Suarez is also in the team’s plans.  Suarez is eligible for arbitration one more time before hitting the open market after the 2025 campaign, and the left-hander’s breakout as a Cy Young Award candidate this season will surely elevate his asking price.  With so much money already committed to the rotation in particular, retaining Sanchez could be the Phillies’ way of creating a hedge if Suarez does depart in free agency, though it wouldn’t be surprising if the Phils again break the bank to keep Suarez on yet another noteworthy extension.

With so much of their rotation now locked up, the Phillies have limited room on paper for top pitching prospects Andrew Painter and Mick Abel.  This could make Philadelphia more open to moving young pitching for more immediate help at this year’s trade deadline, though it should be noted that Abel hasn’t performed well at Triple-A this season and Painter won’t pitch until 2025 due to Tommy John surgery.  Until the Phils have more clarity on their top young arms in particular, Dombrowski would certainly be wary of dealing from the starting ranks.  Spencer Turnbull has excelled when used as a starter this season as well, though he is only signed through this season.

Photo courtesy of USA Today Sports Images

Angels Place Patrick Sandoval On 15-Day IL With Elbow Strain

By | at

TODAY: The Angels announced this evening that Sandoval has been placed on the 15-day injured list with an elbow strain. Right-hander Guillo Zuniga was recalled from Triple-A to take Sandoval’s spot on the active roster. The severity of Sandoval’s injury is not yet clear, though he’s now set to miss at least the next two weeks of action.

June 21: Angels left-hander Patrick Sandoval left tonight’s start against the Dodgers in the third inning. After walking former teammate Shohei Ohtani, Sandoval began shaking his arm and called for a trainer. The Halos announced the initial diagnosis as forearm tightness.

It seems fair to presume Sandoval will head for imaging in the next couple days. While it’s too early to know whether he’s facing a significant absence, the southpaw’s reaction on the mound and the diagnosis are clearly cause for concern.

Sandoval worked 2 1/3 scoreless innings tonight. He still has an uninspiring 5.08 earned run average over 79 2/3 frames on the season. The 27-year-old’s underlying indicators are quite a bit more promising. Sandoval has punched out a solid 23% of batters faced while keeping the ball on the ground 45% of the time. He has issued a few too many walks (9.9% rate), but he looks like a mid-rotation arm at his best. Sandoval carried an above-average 11.7% swinging strike rate into tonight’s start.

Between 2022-23, Sandoval was somewhat quietly one of the better starters in the league. He topped 140 innings in both seasons, combining for a 3.50 ERA over 55 starts. While Sandoval was more effective in ’22 than he was a year ago, he has generally been a bright spot amidst a tough few years in Orange County.

As MLBTR’s Steve Adams explored in a piece for Front Office subscribers just this week, Sandoval looked like a very appealing trade candidate. Steve noted the parallels between the Angels hurler and Miami’s Jesús Luzardo, who is regarded as one of the best (if not the top) controllable starting pitcher who is likely to move this summer. The Angels haven’t shown the same willingness to deal key players as the Marlins’ new front office has, yet Los Angeles GM Perry Minasian would get no shortage of calls on a healthy Sandoval.

Tonight’s injury at least complicates that possibility. An extended absence would take a deadline deal off the table entirely. The Angels control Sandoval via arbitration for two seasons beyond this one. He’s making $5.025MM this season in his second of four arbitration years after qualifying as a Super Two player in 2022.

Marlins Place Jesus Luzardo On 15-Day Injured List

By | at

12:59PM: The move has been officially announced, with Luzardo’s placement retroactive to June 19.  The left-hander’s injury has been termed as a lumbar stress reaction, and Schumaker floated a recovery timeline of 4-6 weeks to De Nicola and other reporters.  Though Schumaker was speaking in more general terms about recoveries from similar injuries rather than what can be expected for Luzardo himself, it nevertheless remains unclear if Luzardo will be able to pitch again before the trade deadline.

10:42AM: The Marlins have placed left-hander Jesus Luzardo on the 15-day injured list due to a back injury.  The team already announced yesterday that Luzardo was being scratched from his planned start today, and Shaun Anderson is being recalled from Triple-A to take the hill against the Mariners.

Luzardo has been trying to pitch through his back problem “for a couple of weeks,” manager Skip Schumaker told MLB.com’s Christina De Nicola and other reporters, and the team even considered scratching him from his previous start against the Nationals last Sunday.  As De Nicola notes, Luzardo’s velocity was down during that outing, though Luzardo still managed five innings of two-run ball against Washington.

“You don’t want to overdo another side of the body or another part of the body because you’re trying not to hurt whatever is being hurt or is hurting,” Schumaker said.  “You definitely don’t want to push through something, especially the back, because it could lead to other things.  So we’ll see what the results say and what the doctors say, but it’s definitely not something that you push through.”

This is Luzardo’s second IL trip this season, as he also missed just under three weeks dealing with tightness in his throwing elbow.  Luzardo has a lengthy and well-documented injury history that also includes a Tommy John surgery, but the 2023 season showed a glimpse of what the southpaw could do when he was finally healthy.  Over 32 starts and 178 2/3 innings for Miami last year, Luzardo posted a 3.58 ERA, 28.1% strikeout rate, and 7.4% walk rate to help lead the Marlins to a wild card berth.

The numbers have fallen off in 2024, with health undoubtedly some sort of factor in Luzardo’s 5.00 ERA over 66 2/3 frames.  While his 4.20 SIERA is a little more respectable, Luzardo’s strikeout rate has sharply dropped to 21.2%, and his fastball velocity has gone from 96.7mph in 2023 to 95.1mph this year.  As per Statcast, Luzardo’s four-seamer was one of the more effective pitches in baseball last season, but is now a below-average offering.

Anderson has already made one spot start for the Marlins since he was acquired in a trade with the Rangers last month, and now might get more opportunities as Miami continues to deal with an injury-plagued rotation.  Since the last-place Marlins have long since thrown in the towel on contending this season, much of the focus on Miami has been around on what the team might do at the trade deadline, with Luzardo’s name often mentioned a prime candidate to be moved.

Even considering his shaky 2024 production, Luzardo has been viewed as possibly the Marlins’ best trade chip due to his age (26) and the two-plus years of arbitration control that runs through the 2026 campaign.  However, this latest injury creates new doubt that Luzardo will even be back on the mound by the July 30 deadline, given how back problems can tend to linger.  There’s no urgency for the Marlins to move Luzardo this summer when other trades could be explored this winter or really at any time during Luzardo’s remaining tenure with the organization, but naturally another injury-marred season will lower his trade value.

Robert Gasser To Undergo UCL Surgery

By | at

June 21: Milwaukee indeed reinstated Junis from the 60-day IL this evening. The Brewers optioned Bradley Blalock to Triple-A Nashville to open a spot on the active roster. Their 40-man roster is at capacity.

June 20: Brewers rookie left-hander Robert Gasser will undergo surgery to fix the UCL in his throwing elbow, he told reporters this evening (X link via Todd Rosiak of the Milwaukee Journal-Sentinel). It won’t be clear until the operation whether he requires a full Tommy John reconstruction or a modified ligament repair. Even in the better scenario of a slightly less significant procedure like the internal brace surgery, Gasser said he expects to miss at least a full calendar year.

The 25-year-old southpaw made his major league debut last month. Gasser found immediate success, working 28 innings of 2.57 ERA ball through his first five starts. The University of Houston product only walked one of the 114 hitters he faced. While he certainly wouldn’t have maintained that level of control, Gasser has been a solid strike-thrower whom most scouts expect to stick in the rotation. Baseball America ranked him the #5 prospect in the Milwaukee system and slotted him among the sport’s top 100 minor league talents entering the season.

Gasser’s initial MLB success might have increased his stock a little bit, even though his 14% strikeout percentage was well below the swing-and-miss rates he’d shown in the minor leagues. He’d certainly performed well enough to continue taking the ball every fifth day in a patchwork Milwaukee rotation. Freddy Peralta and Colin Rea have been the constants. Peralta is the unquestioned staff ace, while Rea has stepped up with a 3.29 ERA over 76 2/3 innings despite a modest 16.7% strikeout rate.

Milwaukee has otherwise cycled through a number of starters as they’ve navigated various injuries. They have lost an entire rotation to extended absences. Wade Miley underwent Tommy John surgery after two starts. Jakob Junis has pitched once all season. DL Hall has been sidelined since April. Joe Ross went down in May with a lower back strain; he suffered a setback a couple weeks ago. Gasser is now also out for the season. That’s not even counting Brandon Woodruff, whom the Brewers knew would miss all of 2024 after he underwent shoulder surgery last October.

Bryse Wilson and Tobias Myers have stepped into the third and fourth rotation spots. While they’ve each managed decent run prevention numbers, neither pitcher is without question marks. Wilson opened the season as a reliever and has an unimpressive strikeout and walk profile as a starter. Myers is a former minor league signee on the sixth organization of his professional career. His 21.7% strikeout rate and 8.7% walk percentage are fine, but he’s had to work around an elevated home run rate.

The fifth rotation spot has recently fallen to Carlos Rodriguez, a rookie who has allowed seven runs in 8 1/3 innings over his first two starts. Junis is nearing a return from the 60-day injured list — MLB.com’s Adam McCalvy tweets that he could be reinstated as soon as tomorrow — but he isn’t expected to immediately step back into a rotation spot. Junis has only made two abbreviated rehab appearances for Triple-A Nashville. The Brewers have suggested he’s likely to work out of the bullpen initially as they try to expedite his return to the major league staff.

In that context, it’s remarkable that the Brewers have managed a 44-30 record and pulled out to a fairly comfortable 7.5 game lead in the NL Central. They’ll almost certainly bring in at least one starting pitcher before the July 30 trade deadline. There’s a reasonable argument for GM Matt Arnold and his staff to land multiple rotation pickups. Losing Gasser should only add to the urgency to address what was the team’s biggest question mark well before their last couple months of terrible injury news.

Gasser is on the MLB injured list and will collect service time and be paid at the league minimum rate for whatever time he spends on the IL. Milwaukee can move him to the 60-day IL to open a 40-man roster spot whenever that need arises. (They already have a vacancy for Junis’ reinstatement after designating Elieser Hernández for assignment last night.) Gasser will not get to a full service year and remains controllable for six seasons beyond this one.

Kyle Bradish Undergoes Tommy John Surgery

By | at

Orioles general manager Mike Elias informed reporters that right-hander Kyle Bradish underwent Tommy John surgery with an internal brace today. He’ll be out for the rest of this year and part of 2025 as well. Danielle Allentuck of the Baltimore Banner was among those to relay the news on X. Additionally, left-hander Danny Coulombe had bone chips removed from his elbow, per Allentuck on X. The southpaw could return this year but is likely out until September.

The Bradish news is a brutal blow for the club’s rotation. He had a tremendous breakout season with the O’s last year, making 30 starts with a 2.83 earned run average. He struck out 25% of batters faced, limited walks to a 6.6% rate and got grounders at a 49.2% clip.

Things got scary here in 2024, as Bradish was diagnosed with a sprain of his UCL in mid-February. The club initially tried non-surgical interventions and seemed to have some success. Bradish was given a platelet-rich plasma injection and was showing “accelerated healing” by early March, per Bradish himself.

Things seemed to accelerate fairly normally from there. Bradish was able to start a rehab assignment by the second week of April and was reinstated from the injured list in early May. He made eight starts for the big league club with a 2.75 ERA. But he landed back on the injured list last week, again due to a sprain of his UCL, with surgery apparently unavoidable this time around.

In hindsight, it would be easy to dismiss the past four months as simply delaying the inevitable, but pitchers have suffered UCL injuries and avoided surgery before. Masahiro Tanaka was diagnosed with a partially torn UCL in 2014, for instance, but never got it repaired and went on to pitch between 150 and 200 innings in each of the five following seasons. Seth Lugo was also found to have a slight tear in 2017 but didn’t go under the knife. More recently, Triston McKenzie was diagnosed with a UCL sprain last summer but has made 14 starts for the Guardians this year.

Given the 14 to 18 months of recovery that are generally needed after Tommy John surgery, pitchers and teams usually prefer to exhaust non-surgical options before surrendering to the surgeon’s table. The O’s and Bradish believed they had a path open to them and tried to take it, but unfortunately couldn’t make it work in this instance.

This is now the third starting pitcher that the Orioles have lost to season-ending UCL surgery this year, as both Tyler Wells and John Means went down this road before Bradish. Despite those losses, the rotation has been a strength overall. Baltimore starter’s have a combined ERA of 3.03 this year, which trails only the Yankees and Phillies. But maintaining such a position without those three will be a challenge.

As of now, the O’s are left with Corbin Burnes, Grayson Rodriguez, Cole Irvin, Cade Povich and Albert Suárez in the rotation, but it seems fair to expect the O’s to pursue additions prior to the July 30 deadline. Povich has just two major league starts under his belt so far. Irvin has a 3.03 ERA on the year but is only striking out 17.9% of batters faced. His 4.16 SIERA this year and his career ERA of 4.24 perhaps suggest some regression is coming. Suárez has a 2.05 ERA but is a 34-year-old journeyman with a 19.7% strikeout rate and 81.9% strand rate.

Dean Kremer should be rejoining that group shortly, as he is on the injured list but currently on a rehab assignment. However, he’s more of a solid back-end guy, with an ERA of 4.35 in his career and a mark of 4.32 this year. In terms of depth options, Levi Stoudt was just claimed off waivers but has a 6.92 ERA in Triple-A this year. Bruce Zimmermann is on the 40-man but hasn’t pitched since mid-May. Jonathan Heasley is also on the roster but has been working as a swingman in the minors.

Last week, Ken Rosenthal of The Athletic reported that the club would be waiting until closer to the deadline to decide on their starting pitching approach. With Bradish now out for the year, that will presumably increase their desire to pursue starting pitching in the months to come. In the meantime, Bradish will be transferred to the 60-day injured list whenever the O’s need his roster spot. He’ll spent the rest of the year on the shelf and will qualify for arbitration this offseason as a Super Two player.

The news on Coulombe isn’t as bad but is still significant. The lefty has a career ERA of 3.57 and that mark is just 2.68 since joining the O’s prior to the 2023 season. He has thrown 77 1/3 innings since coming to Baltimore, striking out 28.5% of batters faced while limiting walks to a 5% clip.

He landed on the IL a week ago due to left elbow inflammation and it now seems he’s going to miss several months, leaving the Orioles with Cionel Pérez, Keegan Akin and Nick Vespi as southpaws in their bullpen.

Like Bradish, Coulombe will be a candidate to be moved to the 60-day IL whenever the O’s need a roster spot for someone else. The two sides avoided an arbitration hearing by agreeing to a one-year deal with a club option in January. That option has a $4MM base salary and escalators that start at 50 appearances. He’s made 29 appearances so far this year but won’t be able to get that number up to 50 if he’s out until September. He will cross six years of service by the end of the season and be a free agent if the O’s decline that option.

Show all

MLB Trade Rumors is not affiliated with Major League Baseball, MLB or MLB.com

Do not Sell or Share My Personal Information

hide arrows scroll to top